Nation

Serum Institute of India applies for emergency approval of covid vaccine candidate ‘Covishield’

Serum Institute of India (SII) has applied for emergency approval of made-in-India covid vaccine candidate, Covishield.

SII CEO Adar Poonawalla has confirmed it and said it will save countless lives.

He also thanked the Government of India and Prime Minister Narendra Modi for their invaluable support.

SII, the world’s largest vaccine producer by volume, had sought emergency use authorization in the country for AstraZeneca Plc’s COVID-19 vaccine candidate.

The company applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large. 

The move comes close on the heels of Pfizer Inc applying for a similar authorization of its coronavirus vaccine in India.

Click to comment

Leave a Reply

Your email address will not be published.

2 × three =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

Address:
D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

West Bengal

Eastern Regional Office
Indsamachar Digital Media
Siddha Gibson 1,
Gibson Lane, 1st floor, R. No. 114,
Kolkata – 700069.
West Bengal.

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us